This site may contain promotional information and is intended only for healthcare professionals resident in the United Kingdom

Search

Menu

Close

Sign InLog Out Medicines & Therapeutic AreaCongressesPublicationsResourcesTrials & ResearchContact

Adverse event reporting can be found at the bottom of the page
Pfizer in the UK

No Beyond Pfizer Medical content is currently available.

Check back soon to see if new content has been added,
or try looking at our other categories or our therapy area specific pages

Video Outcome-Based Agreements -
The Future of Healthcare Systems The content is approved for United Kingdom

Outcome-Based Agreements have the potential to reinvent the way in which new medications are introduced and funded by the NHS. This video explains how their implementation may improve patient access to new therapies.

Learn moreLoading

PP-UNP-GBR-3787. Mar 2023

VideoOutcome-Based Agreements -
The Future of Healthcare Systems The content is approved for United Kingdom

Outcome-Based Agreements have the potential to reinvent the way in which new medications are introduced and funded by the NHS. This video explains how their implementation may improve patient access to new therapies.

 Learn moreLoading

PP-UNP-GBR-3787. Mar 2023

PDFHow to undertake research with Pfizer This content is approved for United KingdomThere are several ways in which HCPs are able to undertake research with Pfizer. We explain the various study types, plus describe grant & collaboration opportunities as well as how HCPs are able to get in touch. 

A more in depth synopsis can be found here Learn moreLoading

PP-UNP-GBR-7979. Jan 2024

PP-UNP-GBR-3585. March 2023
Didn’t find what you are looking for?​​​​​Contact Us

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 
for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

Pfizer Account

To access further materials, resources and receive communication about medicines and vaccines related to Pfizer.

Sign In or RegisterAccount Sign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc 

This website is brought to you by Pfizer Limited, a company registered in England 
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

Copyright © 2024 Pfizer Limited. All rights reserved.

VAT registration number GB201048427
PP-UNP-GBR-7911. Jan 2024

You are now leaving Pfizer MedicalYou are now leaving https://pfizermedical.pfizerpro.co.uk/. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 
Pfizer accepts no responsibility for the content or services of the linked site. 

PP-UNP-GBR-1186 June 2022

This site may contain promotional information and is intended only for healthcare professionals resident in the United Kingdom

The web pages will include information about Pfizer's medicines, vaccines and related therapy areas.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-4060. February 2022

You are now leaving PfizerPro Medical You are now leaving https://pfizermedical.pfizerpro.co.uk/. 
​​​​​​​Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd.
Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to Pfizer’s medicines or business which it has provided or reviewed.
PP-UNP-GBR-1185 June 2022​​​​​​​